Buchumschlag

Nephropathy in type 2 diabetes

Weitere Versionen anzeigen (1)

End-stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most frequent cause of renal replacement therapy in western Europe. The majority of patients with type 2 diabetes and renal failure suffer from diabetic glomerulosclerosis, but non-diabetic renal disease and atypical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Ritz, Eberhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 December 2001
In: Journal of internal medicine
Year: 1999, Jahrgang: 245, Heft: 2, Pages: 111-126
ISSN:1365-2796
DOI:10.1046/j.1365-2796.1999.00411.x
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1365-2796.1999.00411.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2796.1999.00411.x
Volltext
Verfasserangaben:E. Ritz

MARC

LEADER 00000caa a2200000 c 4500
001 1772801259
003 DE-627
005 20230426091828.0
007 cr uuu---uuuuu
008 211008s1999 xx |||||o 00| ||eng c
024 7 |a 10.1046/j.1365-2796.1999.00411.x  |2 doi 
035 |a (DE-627)1772801259 
035 |a (DE-599)KXP1772801259 
035 |a (OCoLC)1341421834 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ritz, Eberhard  |d 1938-2023  |e VerfasserIn  |0 (DE-588)106673386  |0 (DE-627)610528866  |0 (DE-576)311552501  |4 aut 
245 1 0 |a Nephropathy in type 2 diabetes  |c E. Ritz 
264 1 |c 25 December 2001 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.10.2021 
520 |a End-stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most frequent cause of renal replacement therapy in western Europe. The majority of patients with type 2 diabetes and renal failure suffer from diabetic glomerulosclerosis, but non-diabetic renal disease and atypical presentations, e.g. as irreversible acute renal failure or ischaemic nephropathy, play an increasingly important role. Known risk factors for the onset of diabetic nephropathy include (1) genetic predisposition (indicated by a history of hypertension and cardiovascular events in first-degree relatives), (2) quality of glycaemic control, (3) level of blood pressure, and (4) smoking. At the time when type 2 diabetes is diagnosed, an abnormal blood pressure profile is found in approximately 80%. In patients with established diabetic nephropathy, hypertension is the most important factor which promotes progression, and this is susceptible to intervention. Although less data are available for type 2 diabetes (compared with type 1 diabetes), ACE inhibitors appear to be the antihypertensive agent of first choice, but monotherapy is rarely sufficient to achieve the blood pressure goal. Although, at least in principle, diabetic nephropathy is a preventable condition, currently only a minority of type 2 diabetic patients in western Europe receives adequate medical treatment to prevent onset or progression of diabetic nephropathy. Consequently, novel approaches to patient management and interdisciplinary interaction are necessary to fulfil the postulate of the St Vincent declaration concerning prevention of diabetic complications. 
650 4 |a CAPD 
650 4 |a diabetes 
650 4 |a diabetes mellitus 
650 4 |a haemodyalisis 
650 4 |a hypertension 
650 4 |a microalbuminuria 
650 4 |a nephropathy 
773 0 8 |i Enthalten in  |t Journal of internal medicine  |d Oxford [u.a.] : Wiley-Blackwell, 1863  |g 245(1999), 2, Seite 111-126  |h Online-Ressource  |w (DE-627)320457826  |w (DE-600)2006883-9  |w (DE-576)091142881  |x 1365-2796  |7 nnas  |a Nephropathy in type 2 diabetes 
773 1 8 |g volume:245  |g year:1999  |g number:2  |g pages:111-126  |g extent:16  |a Nephropathy in type 2 diabetes 
856 4 0 |u https://doi.org/10.1046/j.1365-2796.1999.00411.x  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2796.1999.00411.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211008 
993 |a Article 
994 |a 1999 
998 |g 106673386  |a Ritz, Eberhard  |m 106673386:Ritz, Eberhard  |d 910000  |d 910100  |e 910000PR106673386  |e 910100PR106673386  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j  |y j 
999 |a KXP-PPN1772801259  |e 3985425779 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 08.10.2021"],"recId":"1772801259","language":["eng"],"title":[{"title_sort":"Nephropathy in type 2 diabetes","title":"Nephropathy in type 2 diabetes"}],"person":[{"role":"aut","display":"Ritz, Eberhard","roleDisplay":"VerfasserIn","given":"Eberhard","family":"Ritz"}],"physDesc":[{"extent":"16 S."}],"relHost":[{"title":[{"title_sort":"Journal of internal medicine","title":"Journal of internal medicine"}],"pubHistory":["1.1863 - 4.1868; [N.F.] 1.1869 -"],"part":{"year":"1999","pages":"111-126","issue":"2","volume":"245","text":"245(1999), 2, Seite 111-126","extent":"16"},"titleAlt":[{"title":"Medicinskt archiv"},{"title":"Nordiskt medicinskt arkiv"},{"title":"Acta medica Scandinavica"}],"note":["Gesehen am 08.04.22"],"disp":"Nephropathy in type 2 diabetesJournal of internal medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320457826","language":["eng"],"origin":[{"dateIssuedDisp":"1863-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedKey":"1863","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]"}],"id":{"issn":["1365-2796"],"zdb":["2006883-9"],"doi":["10.1111/(ISSN)1365-2796"],"eki":["320457826"]},"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"25 December 2001"}],"id":{"eki":["1772801259"],"doi":["10.1046/j.1365-2796.1999.00411.x"]},"name":{"displayForm":["E. Ritz"]}} 
SRT |a RITZEBERHANEPHROPATH2520 

Ähnliche Einträge